Senior insider sale
Chief Medical Officer at NUVATION BIO INC. — senior position signals high conviction
$443.1K
70K shares
What this filing means
LIU DONGFANG plans to sell 70K shares of NUVATION BIO INC. valued at approximately $443.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/26/2025ACC: 0001950047-25-009441
Officer· Chief Medical Officer
Since Jul 2022
70K
Shares to sell
$443.1K
Approx. market value
10K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
11/26/2025
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/26/2025 | Exercise of options under a registered plan Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
10K
Market value
$75.0K
11/25/2025
—Completed
Units to sell
20K
Market value
$140.1K
11/20/2025
—Completed
Units to sell
15K
Market value
$76.6K
11/19/2025
—Completed
Units to sell
15K
Market value
$71.5K
11/17/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
10K
Market value
$80.0K
11/26/2025
Total
Units
70K
Value
$443.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/25/2025 | 10K | $75.0K | — | Completed |
11/20/2025 | 20K | $140.1K | — | Completed |
11/19/2025 | 15K | $76.6K | — | Completed |
11/17/2025 | 15K | $71.5K | — | Completed |
| Planned — Approximate Date | ||||
11/26/2025 | 10K | $80.0K | NYSE | Planned |
| Total | 70K | $443.1K | ||